Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Microsoft Corrects On Solid Results: AI Is Priced Into The Market: https://www.marketbeat.com/logos/articles/med_20230726075228_copy-1-of-chart-msft-7262023.png
Microsoft Corrects On Solid Results: AI Is Priced Into The Market

Microsoft (NASDAQ: MSFT) had an outstanding quarter, but it was not enough to spur the market to rally. The takeaway from the post-release action is that AI is priced into the market, and the

Skeptics In Pulte Homes Next Bull Run May Get Burnt: https://www.marketbeat.com/logos/articles/med_20230726070247_skeptics-in-pulte-homes-next-bull-run-may-get-burn.jpg
Skeptics In Pulte Homes Next Bull Run May Get Burnt

The residential construction sector has seen a stratospheric rise during the past year and a half, with leading dynamics in the underlying economy fueling further demand for housing and further

Earnings Suggest the Worst is Behind 3M, but is MMM a Buy?: https://www.marketbeat.com/logos/articles/med_20230725121750_earnings-suggest-the-worst-may-be-behind-3m-but-is.jpg
Earnings Suggest the Worst is Behind 3M, but is MMM a Buy?

Tech stocks were supposed to be the focus of investors this week. But in mid-day trading on July 25, 3M (NYSE: MMM) stole the spotlight. MMM stock is up 5.7% after reporting a double beat in its

Eilt: Krebs vollständig geheilt - Massives Kaufsignal. Neuer 202% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/71441/Ac-07-26-23-ac1.001.png
Eilt: Krebs vollständig geheilt - Massives Kaufsignal. Neuer 202% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Krebs vollständig geheilt - Massives Kaufsignal. 202% Biotech Hot Stock nach 134.452% mit Biogen ($BIIB)

 

26.07.23 08:02

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Eilt: Krebs vollständig geheilt - Massives Kaufsignal. Neuer 202% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/71441/Ac-07-26-23-ac1.001.png
Eilt: Krebs vollständig geheilt - Massives Kaufsignal. Neuer 202% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Krebs vollständig geheilt - Massives Kaufsignal. 202% Biotech Hot Stock nach 134.452% mit Biogen ($BIIB)

 

26.07.23 08:02

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Eilt: Krebs vollständig geheilt - Massives Kaufsignal. Neuer 202% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/71441/Ac-07-26-23-ac1.001.png
Eilt: Krebs vollständig geheilt - Massives Kaufsignal. Neuer 202% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Krebs vollständig geheilt - Massives Kaufsignal. 202% Biotech Hot Stock nach 134.452% mit Biogen ($BIIB)

 

26.07.23 08:02

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Kimberly-Clark Raises Sales and Profit Guidance, Can it Breakout?: https://www.marketbeat.com/logos/articles/med_20230725094457_kimberly-clark-raises-sales-and-profit-guidance-ca.jpg
Kimberly-Clark Raises Sales and Profit Guidance, Can it Breakout?

In May 2023, Kimberly-Clark Corporation (NYSE: KMB) stock climbed to a 52-week high of $147.87. However, the stock has failed to hold those gains and heading into the company’s earnings report, KMB

Masimo, Medical Device Maker Drops on Q2 Guidance, Opportunity?: https://www.marketbeat.com/logos/articles/med_20230725080758_masimo-medical-device-maker-drops-on-q2-guidance-o.jpg
Masimo, Medical Device Maker Drops on Q2 Guidance, Opportunity?

Shares of health monitoring technology maker Masimo Corporation (NASDAQ: MASI) dropped 24% to $114.30 last week due to a second-quarter performance warning. They are at their lowest level since

US Foods is Managing Inflation Deceleration the Right Way: https://www.marketbeat.com/logos/articles/med_20230723162601_chart-usfd.jpg
US Foods is Managing Inflation Deceleration the Right Way

In all industries, some companies are a cut above the rest. They are just better managed. Inflation has been on a wild ride hitting a high of 9.1% in June 2022 and falling to 4.8% by June 2023. The

Rebound And Reversal For Logitech International: https://www.marketbeat.com/logos/articles/med_20230725074437_chart-logi-7252023.png
Rebound And Reversal For Logitech International

Logitech’s (NASDAQ: LOGI) Q1 results were better than expected and have the stock in a position to rebound from long-term lows and confirm a reversal in the market. The move is foreshadowed by

Energy Stocks Bullish, But Futures Market Signals Trouble Ahead: https://www.marketbeat.com/logos/articles/med_20230725073245_energy-stocks-bullish-but-futures-market-signals-t.jpg
Energy Stocks Bullish, But Futures Market Signals Trouble Ahead

The Energy Select Sector SPDR Fund (NYSEARCA: XLE) was trading higher for the fifth session in a row on July 24, extending that streak with a gap up at the open. 

However, some analysts are

Energy Stocks Bullish, But Futures Market Signals Trouble Ahead: https://www.marketbeat.com/logos/articles/med_20230725073245_energy-stocks-bullish-but-futures-market-signals-t.jpg
Energy Stocks Bullish, But Futures Market Signals Trouble Ahead

The Energy Select Sector SPDR Fund (NYSEARCA: XLE) was trading higher for the fifth session in a row on July 24, extending that streak with a gap up at the open. 

However, some analysts are

There’s A Buying Opportunity Opening Up With Cadence Design: https://www.marketbeat.com/logos/articles/med_20230725072626_theres-a-buying-opportunity-opening-up-with-cadenc.jpg
There’s A Buying Opportunity Opening Up With Cadence Design

Cadence Design Systems Inc (NASDAQ: CDNS) is a stock that we’ve heard about more and more recently, helped no doubt by its 55% run since the start of the year. The San Jose headquartered company

'Barbie' The Movie Is a Winner...But Is Mattel's Stock?: https://www.marketbeat.com/logos/articles/med_20230725072901_barbie-the-movie-is-a-winner.jpg
'Barbie' The Movie Is a Winner...But Is Mattel's Stock?

Mattel, Inc. (NASDAQ: MAT) shareholders were tickled pink on Monday after the highly anticipated ‘Barbie’ movie lived up to the hype over the weekend. 

After debuting nationwide July 21st, the film

Will Cloudflare Go Back Into Rally Mode After Q2 Earnings Report?: https://www.marketbeat.com/logos/articles/med_20230724141154_will-cloudflare-go-back-into-rally-mode-after-q2-e.jpg
Will Cloudflare Go Back Into Rally Mode After Q2 Earnings Report?

The recent rally in erstwhile tech leader Cloudflare Inc. (NYSE: NET) is a good reminder of why it’s important to stay up to speed on sector rotation, as it can have a big impact on your overall

Will Cloudflare Go Back Into Rally Mode After Q2 Earnings Report?: https://www.marketbeat.com/logos/articles/med_20230724141154_will-cloudflare-go-back-into-rally-mode-after-q2-e.jpg
Will Cloudflare Go Back Into Rally Mode After Q2 Earnings Report?

The recent rally in erstwhile tech leader Cloudflare Inc. (NYSE: NET) is a good reminder of why it’s important to stay up to speed on sector rotation, as it can have a big impact on your overall

Will Cloudflare Go Back Into Rally Mode After Q2 Earnings Report?: https://www.marketbeat.com/logos/articles/med_20230724141154_will-cloudflare-go-back-into-rally-mode-after-q2-e.jpg
Will Cloudflare Go Back Into Rally Mode After Q2 Earnings Report?

The recent rally in erstwhile tech leader Cloudflare Inc. (NYSE: NET) is a good reminder of why it’s important to stay up to speed on sector rotation, as it can have a big impact on your overall

Will Cloudflare Go Back Into Rally Mode After Q2 Earnings Report?: https://www.marketbeat.com/logos/articles/med_20230724141154_will-cloudflare-go-back-into-rally-mode-after-q2-e.jpg
Will Cloudflare Go Back Into Rally Mode After Q2 Earnings Report?

The recent rally in erstwhile tech leader Cloudflare Inc. (NYSE: NET) is a good reminder of why it’s important to stay up to speed on sector rotation, as it can have a big impact on your overall

Will Q2 Earnings Propel Payment Processor Shift4?: https://www.marketbeat.com/logos/articles/med_20230724122738_will-q2-earnings-propel-payment-processor-shift4.jpg
Will Q2 Earnings Propel Payment Processor Shift4?

Payment processing specialist Shift4 Payments Inc. (NYSE: FOUR) formed a bullish base below resistance at $76.40. Its second-quarter earnings report on August 3 is a possible catalyst for a

Will Q2 Earnings Propel Payment Processor Shift4?: https://www.marketbeat.com/logos/articles/med_20230724122738_will-q2-earnings-propel-payment-processor-shift4.jpg
Will Q2 Earnings Propel Payment Processor Shift4?

Payment processing specialist Shift4 Payments Inc. (NYSE: FOUR) formed a bullish base below resistance at $76.40. Its second-quarter earnings report on August 3 is a possible catalyst for a

Will Q2 Earnings Propel Payment Processor Shift4?: https://www.marketbeat.com/logos/articles/med_20230724122738_will-q2-earnings-propel-payment-processor-shift4.jpg
Will Q2 Earnings Propel Payment Processor Shift4?

Payment processing specialist Shift4 Payments Inc. (NYSE: FOUR) formed a bullish base below resistance at $76.40. Its second-quarter earnings report on August 3 is a possible catalyst for a